← Leaderboards
Jiaxin Liang
Dana-Farber Cancer Inst
$506,596
Attributed
$506,596
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $377.8K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$506,596 · 2
By mechanism
K99$257,596 · 1
R00$249,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Kai W Wucherpfennig$37,935,181
- Toni Choueiri$2,782,193
- Piotr Sicinski$42,703,610
- Frank S Hodi$11,927,265
- Patrick Alexander Ott$3,127,186
Others in their field
Other Rising Stars on “Anti-Tumor Immune Response”
- Dmitriy Zamarin · Sloan-Kettering Inst Can Research$3,530,063
- Mark Yarchoan · Johns Hopkins University$3,378,705
- Debattama Rai Sen · Massachusetts General Hospital$2,502,000
- Arta Monir Monjazeb · University Of California At Davis$2,398,453
- Megan K Ruhland · Oregon Health & Science University$2,265,578
- John James Blazeck · Georgia Institute Of Technology$2,260,963
Research focus
Anti-Tumor Immune ResponseAwardBetaineBisulfite SequencingCareer DevelopmentCd8b1 GeneCd8-Positive T-LymphocytesCellsCholineClinical TreatmentCollaborationsCombined Modality TherapyCommunitiesComplexDana-Farber Cancer InstituteDevelopment PlansDown-RegulationEctopic ExpressionEffector T CellEfficacy EvaluationEnvironmentEnzymesEvaluationAntigen Presentation
Grant awards (3)
Targeting mitochondrial vulnerabilities to drive intrinsic melanoma immunogenicity$249,000
R00 · FY2025 · CA · contact PI
Targeting mitochondrial vulnerabilities to drive intrinsic melanoma immunogenicity$128,798
K99 · FY2025 · CA · contact PI
Targeting mitochondrial vulnerabilities to drive intrinsic melanoma immunogenicity$128,798
K99 · FY2024 · CA · contact PI